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On 31 December 2019, the World Health Organization reported the 
emergence of an outbreak of pneumonia cases in Wuhan, China. The 
disease was later termed coronavirus disease 2019 (COVID-19) and the 
causative agent was identified as a novel coronavirus, SARS-CoV-2. [1] 
The first case of COVID-19 in South Africa (SA) was announced 
on 5 March 2020, and a cumulative total of ~1.5 million confirmed 
cases and 50 000 deaths had been recorded by 7 March 2021.[2,3] The 
COVID-19 vaccination roll-out for healthcare workers (phase 1) was 
planned for February 2021 using the Oxford AstraZeneca vaccine. [4,5] 
However, concerns arose about the efficacy of COVID-19 vaccine 
candidates in the context of dominance of the B.1.351 variant, as it 
contained mutations at the receptor-binding domain of the virus, the 
target site of many vaccines.[6,7] Further data analysis revealed that a 
two-dose regimen of the AstraZeneca ChAdOx1 nCoV-19 vaccine had 
an efficacy of 10.4% against mild to moderate COVID-19 caused by 
the B.1.351 variant.[8] In contrast, interim analysis of the single-dose 
Johnson & Johnson/Janssen Ad26.COV2.S vaccine (J&J) demonstrated 
57% protection against the B.1.351 lineage of SARS-CoV-2 and 
complete protection against COVID-19 hospitalisation and death.[9] 
These findings led to a public announcement on 7 February 2021 that 
healthcare workers would be vaccinated through an implementation 
study using the J&J vaccine, under the name Sisonke Early Access 
Vaccine Rollout for Healthcare Workers.[10,11]
A core vaccine team was formed at Chris Hani Baragwanath 
Academic Hospital (CHBAH) on 13 January 2021. CHBAH is the 
largest hospital in the southern hemisphere and the third-largest in 
the world, with a bed capacity of 3 200 beds and a staff complement 
of ~7 400.[12] The facility is located in Soweto, a peri-urban town 
27  km south-west of Johannesburg in the most populous province 
of the country, Gauteng.[12] The hospital serves a population of 
>1.3 million people, and offers a full range of generalised specialist 
and subspecialist services.[12]
The vaccine team planned for a ‘mass vaccination’ roll-out of staff 
on the launch date, 17 February 2021. Mass vaccination strategies 
are considered to be most useful in pandemic situations, as they 
allow for the fast and efficient vaccination of a large number of 
susceptible people, using a central vaccination site.[13] The benefits 
of mass vaccination of healthcare worker programmes over ward-to-
ward-based vaccination programmes are: (i) a streamlined process 
for pharmacy vaccine delivery, preparation and secure storage, while 
also ensuring that the cold chain is maintained; (ii) easy access to 
an emergency care team that remains in the vaccination site in the 
event of adverse events following immunisation (AEFIs); and (iii) a 
centrally controlled data capture system. Disadvantages include the 
need for a large number of staff to support the mass vaccination 
process itself, requiring precision and careful planning.[14,15] There 
is a paucity of peer-reviewed literature on the implementation of 
mass vaccination programmes, particularly in low-resource, low-
technology settings.[16-18]
Logistical concerns of the mass 
vaccination campaign
The core team began by meeting with various key stakeholders 
such as pharmacy management, the Sisonke study investigators, 
occupational health and safety (OHS) and labour unions. Major 
work streams and tasks were identified (Table 1). In addition, a large 
number of staff was required (Table 2). The majority of the staff who 
volunteered to support the vaccine roll-out were clinicians: doctors 
of all ranks, nurses of all ranks, psychologists, physiotherapists, and 
occupational and speech therapists.
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We identified a large, well-ventilated hall as the most suitable 
vaccination site, and formed a venue operation centre team to assist 
with the set-up and infrastructure of the vaccination site. Additional 
needs were a large outdoor tent to serve as a waiting area; procuring 
furniture and equipment for the vaccination site; demarcating spaces 
for parking, assembly, a waiting area, a vaccination area and an 
observation area; the provision of computers and connectivity for 
data capturing; and a reliable power supply with a back-up generator 
(Fig. 1).
The vaccine roll-out process
Our preparation for mass vaccination at CHBAH involved creation 
of a staff database from human resources, line managers, and 
self-completed electronic registration forms. Using this database, 
vaccination appointments were scheduled by email or text messages. 
Staff had the opportunity to reschedule their appointments based 
on availability. The preregistration booking system was intended 
to minimise time spent away from the staff working areas and the 
impact on service delivery, and to allow for social distancing.
Our vaccinators were drawn from a pool of nurses who were trained 
and accredited using the national COVID-19 Vaccination Training 
for Healthcare Workers online course by the nursing education team 
at CHBAH. The training included infection prevention and control 
measures on appropriate personal protective equipment to be worn, 
and sanitisation of their individual vaccination stations. To allow 
for social distancing while optimising efficiency, the vaccinator 
stations were arranged into four rows (A, B, C, D), each comprising 
six vaccinator stations (A1 - 6, B1 - 6, C1 - 6, D1 - 6), which allowed 
for 24 vaccinator stations in total (Fig. 2). Distribution of vaccine 
doses to the vaccinators was co-ordinated by pharmacy teams and 
OHS nurses prior to the vaccinees entering the vaccination hall. The 
pharmacy and OHS teams were also responsible for the reconciliation 
of all vaccine doses dispensed after each round of 24 vaccinees.
The vaccination process, as depicted in Fig. 2, involved: 
• Scheduled vaccinees arrived at the vaccination site with a form of 
identification and proof of booking.
• Vaccinees were directed to the registration tent, where they were 
screened for COVID symptoms, and gave consent for vaccination.
• Vaccinees were then asked to seat themselves in the waiting area.
• Any extra paperwork was completed and information on the 
process was provided to the vaccinees by a co-ordinator.
• Vaccinees were directed into the vaccination hall in groups of 24 
at a time (24 vaccination stations accommodated by 24 vaccinees 
in each round).
• Vaccinees were asked to leave the hall after vaccination, to be 
observed for 15 minutes in the observation area.
• Any vaccinee who was unwell was immediately taken to the 
emergency medicine team, who were stationed behind screens on 
the side of the vaccination hall (Fig. 2).
This process continued throughout the day, with tea and lunch breaks 
for vaccinators and co-ordinators coinciding with times needed for 
Table 1. Work stream planning for Chris Hani Baragwanath Academic Hospital mass vaccination campaign
Work streams Stream leaders Tasks
Staff education to build vaccine confidence Public relations officer • Information pamphlets printed and distributed at staff entrances
• ‘Town hall’ online meetings
• Staff education via social media (e.g. Facebook)
• Targeted onsite information sessions
Categorisation of staff and databases Line managers and 
administrators
• Categorisation of staff according to risk priority groups
• Pre-registration for willingness to vaccinate (electronic form)
• Schedule vaccination appointments and compile registration lists 
Pharmacy preparation and monitoring Pharmacy manager • Standard operating procedure for vaccine handling and transfer
• Ensure cold chain – access to fridge and cooler boxes
• Security of vaccine vials
Vaccinator identification and training Vaccinator team leader • Vaccinator identification and training
Emergency medical team for AEFIs Emergency team leader • Resuscitation trolley and emergency drugs
• Transport (stretchers, wheelchairs and ambulance services)
OHS OHS team leader • Have mechanisms for reporting AEFIs
• Medical support for staff with delayed adverse events
• Ensure adequate supply of consumables (e.g. cotton swabs) 
Vaccination site and VOC VOC team 
Meeting and co-ordination • Regular site meetings with teams
• Troubleshooting problems
Site layout and mapping • Site map and layout
Equipment • Vaccinator stations (desk and chairs)
Staffing the site • Vaccinators and support staff allocation and shifts
Disaster management and evacuation • Emergency exits and evacuation routes
• Fire marshal and extinguishers
Cleaning and waste management • Waste management and sharps disposal
• Personal protective equipment
• Sanitising station and surfaces
• Deep clean at start and end of session 
Security and ushering • Zoning and unidirectional flow
OHS = occupational health and safety; AEFIs = adverse events following immunisation; VOC = venue operation centre.
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the pharmacy to replenish vaccine stock. Multiple co-ordinators (n=14) 
were required in our mass vaccination roll-out, and this contributed to 
the overall organisation, precision and teamwork that led to a successful 
campaign (Table 2). Our process emphasised the importance of piloting the 
programme on day 1, troubleshooting and adapting at the end of each day. 
We were able to vaccinate 5 659 staff by the end of our 8-day vaccination 
campaign, with 32 vaccinated on day 1, and gradually upscaling to 1 160 
vaccinated on day 8 (Table 3).
Pitfalls and unique challenges
Initial pitfalls identified in our mass vaccination planning included: 
• An objective method for categorisation of staff according to their risk of 
acquiring severe COVID-19 disease was lacking: we couldn’t guarantee 
that all staff at highest risk would be vaccinated first.
• An effective booking system taking into account staff availability was 
lacking, owing to the scale of administrative support needed.
• Reliance on clinicians to staff the vaccination site without providing 
back-up clinical support or de-escalation of clinical services during 
the roll-out period. Clinician-led services are widely lauded for their 
success; however, when this process is employed, it should be a 
dedicated responsibility and should not compromise patient care.[19]
• The urgency of the roll-out and the change from the AstraZeneca to 
the J&J vaccine. This process resulted in new stakeholders, the need to 
implement a national electronic booking system, and a limited daily 
supply of vaccine doses.
• Our team was additionally tasked with assisting other frontline private 
and public sector healthcare workers, which was not initially planned for.
• External factors such as visits by dignitaries and media to the vaccine site.
Lessons learned from a mass vaccination 
campaign
• Choose a vaccination site on the basis of good ventilation, space, lighting, 
toilets and shelter for poor weather conditions. Ensure unidirectional flow 
of vaccinees through the site, with adequate space in an observation area.
• Find a team of passionate, motivated individuals. Ensure that vaccinators 
are trained, supported and rested. Donations of refreshments went a long 
way to boost morale.
• Pharmacy teams need training on storage and preparation of the vaccine.
• Strengthen the OHS team, as they are needed to drive the vaccination 
process and ‘mop up’ afterwards. OHS must prepare for AEFIs at a 
dedicated OHS vaccination clinic.
• Communication between all stakeholders is essential, especially on 
vaccination days: have clear channels of communication between the site 
vaccination team and the pharmacy.
• Ensure fast and reliable internet connectivity, as well as electricity and 
a back-up generator. Ideally have a pre-registration booking system and 
a back-up list for each day to avoid wastage of vaccine doses. Generate 
‘batches’ of vaccinees as per risk categorisation, and provide vaccine 
appointments timeously.
• Encourage visible involvement from hospital management – this adds 
credibility and confidence to the vaccine campaign.
• Conduct a ‘dry-run’ or simulation of the vaccination process before 
starting the roll-out.
• Pilot the process on day 1 before scaling up: prepare to change the plan 
as it unfolds, taking into account the demands and pressure from other 
stakeholders.
Conclusions
The mass vaccination strategy developed and implemented at CHBAH 
was targeted at healthcare workers. Since the launch, our strategy has 




























































































































































































































































































































































































































































































































































































































































































10  9    8   7   6    5   4   3    2   1 
10  9    8   7   6    5   4   3    2   1 
10  9    8   7   6    5   4   3    2   1 
10  9    8   7   6    5   4   3    2   1 
Emergency area




Veranda area for 15-minute post-vaccination 
screening
Exit gate
Stage – for co-ordinators/adm
in
6          5          4          3          2          1
6          5          4          3          2          1
6          5          4          3          2          1
6          5          4          3          2          1
Fig, 2. Vaccination process at Chris Hani Baragwanath Academic Hospital.
Table 2. Staff requirements at vaccination site per day
Category Function Number needed at vaccination site
Vaccinators Administer vaccinations to vaccinees, completion of forms and 
vaccine cards
Online EVDS data capture if possible
24 (4 rows with 6 vaccinators per 
row)
OHS nurses Assist with distribution of vaccines doses to vaccinator stations, 
collection of completed vaccination forms
4
Emergency/ICU team Emergency services as required 2 doctors + 1 nurse
Data capturers Capture of the vaccination form information into the EVDS system 5
Pharmacists Monitoring of vaccinations, checking of stock, ensuring compliance 
with cold chain
2
Site co-ordinator Overseeing all components of the vaccination site, different stations 
and primary point of contact
1
Information station co-ordinators Greeting potential vaccinees, confirming identification and booking 
documents
3
EVDS station co-ordinators Overseeing the EVDS data system and data capturing 1 + 4 personnel
Registration co-ordinators Oversight of registration process, confirming booking on 
registration list, COVID-19 symptom screening and signature for 
consent
1 + 8 personnel
Waiting area co-ordinators Oversight of assembly into waiting area and assisting with 
completion of any paperwork
1 + 2 ushers
Foyer co-ordinators Guiding movement of vaccinees into vaccination hall 1 + 2 ushers
Hall co-ordinator Ensures the smooth operations of the vaccination hall, instructs 
rows to be marshaled in and out
Co-ordinates movement of vaccinees into the hall
1
Row co-ordinators Assists OHS with distribution of syringes, ensures completion 
of vaccinator forms, troubleshoots problems within row, ensures 
functionality of row
4
Observation co-ordinators Oversight of exit from vaccination hall into observation area, 
observes vaccinees for any adverse effects and instructs on 
appropriate next steps
1 doctor + 2 nurses
EVDS = electronic vaccine data system; OHS = occupational health and safety; ICU = intensive care unit.
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a committed core lead team, including pharmacists and clinicians, 
support from managers and a suitable venue, mass vaccination 
campaigns can be successfully rolled out in resource-limited settings. 
Innovation, adaptability and teamwork are critical.
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Table 3. Numbers of vaccine doses administered at Chris Hani Baragwanath Academic Hospital during mass vaccination roll-out  
to healthcare workers
Date Number of vaccine doses administered





24 February 1 018
25 February 1 138
26 February 1 160
